{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:03:08Z","timestamp":1772492588511,"version":"3.50.1"},"reference-count":46,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1750,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1111\/j.1472-8206.2010.00893.x","type":"journal-article","created":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T09:19:23Z","timestamp":1289899163000},"page":"723-733","source":"Crossref","is-referenced-by-count":27,"title":["The correlation between NF-\u03baB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis"],"prefix":"10.1111","volume":"25","author":[{"given":"Hadi","family":"Esmaily","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanollah","family":"Vaziri-Bami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir Ebrahim","family":"Miroliaee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Baeeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","volume":"14","author":"Sanchez-Munoz","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/01.MIB.0000195385.19268.68","article-title":"Inflammatory bowel disease: epidemiology, and therapeutic opportunities","volume":"1","author":"Hanauer","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1053\/j.gastro.2004.03.024","article-title":"Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1007\/s10620-007-0171-0","article-title":"A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn\u2019s disease","volume":"53","author":"Rahimi","year":"2008","journal-title":"Dig. Dis. Sci."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nri1132","article-title":"The immunological and genetic basis of inflammatory bowel disease","volume":"3","author":"Bouma","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/gut.43.6.856","article-title":"Role of NF-kappaB in immune and inflammatory responses in the gut","volume":"43","author":"Neurath","year":"1998","journal-title":"Gut"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1126\/science.270.5234.283","article-title":"Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids","volume":"270","author":"Scheinman","year":"1995","journal-title":"Science"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10620-008-0368-x","article-title":"On the use of herbal medicines in management of inflammatory bowel diseases: a systematic review of animal and human studies","volume":"54","author":"Rahimi","year":"2009","journal-title":"Dig. Dis. Sci."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/092986707779941159","article-title":"Silybin and silymarin - new and emerging applications in medicine","volume":"14","author":"Gaz\u00e1k","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB11|cit11","first-page":"1285","article-title":"Milk thistle","volume":"72","author":"Rainone","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bcp.2003.08.032","article-title":"Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin","volume":"67","author":"Kang","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2478\/s11535-009-0014-4","article-title":"Improvement of inflammatory and toxic stress biomarkers by silymarin in a murine model of type one diabetes mellitus","volume":"4","author":"Malihi","year":"2009","journal-title":"Cent. Eur. J. Biol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"6800","DOI":"10.4049\/jimmunol.163.12.6800","article-title":"Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis","volume":"163","author":"Manna","year":"1999","journal-title":"J. Immunol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2165\/00003495-200161140-00003","article-title":"The use of silymarin in the treatment of liver diseases","volume":"61","author":"Saller","year":"2001","journal-title":"Drugs"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2478\/s11535-008-0053-2","article-title":"On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells","volume":"4","author":"Esmaily","year":"2009","journal-title":"Cent. Eur. J. Biol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0168-8278(01)00092-7","article-title":"Ursodeoxycholic acid \u2018mechanisms of action and clinical use in hepatobiliary disorders\u2019","volume":"35","author":"Lazaridis","year":"2001","journal-title":"J. Hepatol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/BF02994760","article-title":"Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1 beta and nitric oxide in rat microglia","volume":"26","author":"Joo","year":"2003","journal-title":"Arch. Pharm. Res."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1006\/bbrc.1999.1403","article-title":"Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants","volume":"263","author":"Mitsuyoshi","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(93)90653-T","article-title":"Molecular aspects of membrane stabilization by ursodeoxycholate","volume":"104","author":"G\u00fcld\u00fctuna","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1172\/JCI1325","article-title":"A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation","volume":"101","author":"Rodrigues","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/BF02975850","article-title":"Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2)","volume":"27","author":"Joo","year":"2004","journal-title":"Arch. Pharm. Res."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1016\/j.lfs.2007.02.042","article-title":"Protective effect of ursodeoxycholic acid on liver mitochondrial function in rats with alloxan-induced diabetes: link with oxidative stress","volume":"80","author":"Lukivskaya","year":"2007","journal-title":"Life Sci."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/carcin\/bgq011","article-title":"Bile acids modulate the Golgi membrane fission process via a protein kinase Ceta and protein kinase D-dependent pathway in colonic epithelial cells","volume":"31","author":"Byrne","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB25|cit25","first-page":"1205","article-title":"Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis","volume":"9","author":"Kullmann","year":"1997","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vascn.2003.12.002","article-title":"Animal models of inflammatory bowel disease","volume":"50","author":"Jurjus","year":"2004","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.arcmed.2005.03.007","article-title":"Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients","volume":"36","author":"Astaneie","year":"2005","journal-title":"Arch. Med. Res."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/ecam\/nel051","article-title":"Benefits of Zataria multiflora Boiss in Experimental Model of Mouse Inflammatory Bowel Disease","volume":"4","author":"Nakhai","year":"2007","journal-title":"Evid Based Complement Alternat. Med."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0952-7915(99)00032-1","article-title":"Animal models of mucosal inflammation and their relation to human inflammatory bowel disease","volume":"11","author":"Blumberg","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"6680","DOI":"10.1038\/sj.onc.1209954","article-title":"Introduction to NF-kappaB: players, pathways, perspectives","volume":"25","author":"Gilmore","year":"2006","journal-title":"Oncogene"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ibd.3780050209","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB34|cit34","first-page":"358","article-title":"The mechanism by which interleukin-1 beta reduces net fluid absorption from the rat colon","volume":"13","author":"Kreydiyyeh","year":"2002","journal-title":"Eur. Cytokine Netw."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2007.08.031","article-title":"Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production","volume":"578","author":"Ishizaki","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10620-006-9622-2","article-title":"Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?","volume":"52","author":"Rezaie","year":"2007","journal-title":"Dig. Dis. Sci."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1196\/annals.1378.060","article-title":"Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-\u03b21 in relation to disease activity in Crohn\u2019s disease patients","volume":"1091","author":"Rezaie","year":"2006","journal-title":"Ann. N Y Acad. Sci."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(03)00003-2","article-title":"Protein carbonyl groups as biomarkers of oxidative stress","volume":"329","author":"Dalle-Donne","year":"2003","journal-title":"Clin. Chim. Acta"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.numecd.2005.05.003","article-title":"A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress","volume":"15","author":"Del Rio","year":"2005","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB40|cit40","first-page":"491","article-title":"Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine","volume":"124","author":"Pradhan","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/187221409787002949","article-title":"Current opinion in the pharmaceutical management of irritable and inflammatory bowel diseases: role of ATP","volume":"3","author":"Salari","year":"2009","journal-title":"Recent Pat Endocr. Metab. Immune Drug Discov."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.clinthera.2006.12.012","article-title":"A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn\u2019s disease","volume":"28","author":"Rahimi","year":"2006","journal-title":"Clin. Ther."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s10350-008-9335-z","article-title":"Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials","volume":"51","author":"Nikfar","year":"2008","journal-title":"Dis. Colon Rectum"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biopha.2006.06.022","article-title":"Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn\u2019s disease? A systematic meta-analysis of controlled clinical trials","volume":"61","author":"Rahimi","year":"2007","journal-title":"Biomed. Pharmacother."},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2174\/187152808785748164","article-title":"Potassium channel openers and improvement of toxic stress: do they have role in the management of inflammatory bowel disease?","volume":"7","author":"Hosseini-Tabatabaei","year":"2008","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"10.1111\/j.1472-8206.2010.00893.x-BIB46|cit46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002234.pub2","article-title":"Ursodeoxycholic acid for primary biliary cirrhosis","author":"Gluud","year":"2002","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Fundamental &amp; Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1472-8206.2010.00893.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1472-8206.2010.00893.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T06:31:15Z","timestamp":1685860275000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1472-8206.2010.00893.x"}},"subtitle":["Silibinin-ursodeoxycholic acid combination ameliorate TNBS-induced colitis in rats"],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1472-8206.2010.00893.x","relation":{},"ISSN":["0767-3981"],"issn-type":[{"value":"0767-3981","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11,16]]}}}